Literature DB >> 2345754

Is experimental catalepsy properly measured?

S Ferré1, T Guix, G Prat, F Jane, M Casas.   

Abstract

Following logarithmic transformation (ln) of total duration of haloperidol-induced catalepsy in the rat, measured by means of the bar test, a normalization of the results is achieved. With the help of this transformation we have been able to study what are probably the most important variables involved in the measuring of experimental catalepsy and to establish some criteria for a better use of such measures: 1) repeated measures of catalepsy have to be taken in order to avoid the stress-induced inhibition of catalepsy caused by the new experimental situation, 2) the dose of neuroleptic used has to be sufficiently low to permit the measurement of total or real duration of catalepsy between two determinations, and 3) the dose of neuroleptic has to be sufficiently high to prevent the development of a learned "pseudocatalepsy."

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345754     DOI: 10.1016/0091-3057(90)90354-k

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  14 in total

1.  Evaluation of the potential of antipsychotic agents to induce catalepsy in rats: assessment of a new, commercially available, semi-automated instrument.

Authors:  Barbara Bricker; Dinithia Sampson; Seth Y Ablordeppey
Journal:  Pharmacol Biochem Behav       Date:  2014-02-21       Impact factor: 3.533

2.  Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.

Authors:  Catherine F Moore; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2021-10-15       Impact factor: 4.415

3.  The adenosine receptor antagonist theophylline induces a monoamine-dependent increase of the anticataleptic effects of NMDA receptor antagonists.

Authors:  W Hauber; M Münkle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

4.  Anticataleptic and antiepileptic activity of ethanolic extract of leaves of Mucuna pruriens: A study on role of dopaminergic system in epilepsy in albino rats.

Authors:  D Champatisingh; P K Sahu; A Pal; G S Nanda
Journal:  Indian J Pharmacol       Date:  2011-04       Impact factor: 1.200

5.  Antihistaminic activity of aqueous extract of stem bark of Ailanthus excelsa Roxb.

Authors:  Dinesh Kumar; Z A Bhat; P Singh; S S Bhujbal; R S Deoda
Journal:  Pharmacognosy Res       Date:  2011-07

6.  Antihistaminic effect of Bauhinia racemosa leaves.

Authors:  Sa Nirmal; Rb Laware; R A Rathi; Vv Dhasade; Bs Kuchekar
Journal:  J Young Pharm       Date:  2011-04

7.  Anti-dopaminergic effect of the methanolic extract of Morus alba L. leaves.

Authors:  Adhikrao V Yadav; Vandana S Nade
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

8.  Neuroprotective potential of Beta vulgaris L. in Parkinson's disease.

Authors:  Vandana S Nade; Laxman A Kawale; Shankar S Zambre; Amit B Kapure
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

9.  Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models.

Authors:  David D Obiri; Newman Osafo; Regina E Abotsi
Journal:  ISRN Pharmacol       Date:  2013-09-17

10.  Protective Effect of Standardized Extract of Passiflora incarnata Flower in Parkinson's and Alzheimer's Disease.

Authors:  Suvarna P Ingale; Sanjay B Kasture
Journal:  Anc Sci Life       Date:  2017 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.